General Information of Drug (ID: DM95T5Z)

Drug Name
Sapablursen
Indication
Disease Entry ICD 11 Status REF
Polycythemia vera 2A20.4 Phase 2 [1]
Drug Type
Ligand-conjugated antisense
Cross-matching ID
UNII
DXS4HJC32N
DrugBank ID
DB18608
TTD ID
D9VR6X

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
TMPRSS6 messenger RNA (TMPRSS6 mRNA) TTNIUKC TMPS6_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05143957) A Phase 2a, Randomized, Open-Label Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered to Patients With Phlebotomy Dependent Polycythemia Vera (PD-PV). U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Ionis